Dermatol. praxi. 2018;12(4):191-194 | DOI: 10.36290/der.2018.031

Successful treatment of hidradenitis suppurativa in young woman

MUDr. Petra Fialová, prof. MUDr. Vladimír Vašků, CSc.
I. dermatovenerologická klinika FN u sv. Anny a LF MU v Brně

Hidradenitis suppurativa (HS) is a chronic recurrent inflammatory disease affecting mainly young active people. The frequencyof HS is three times higher among females than men. HS is characterized by deep painful nodules in apocrine gland areas. HShas negative impact on patient‘s quality of life involving physical, social and economic aspects. The treatment of HS dependson severity of the disease and on its activity. The combined treatment – medical and surgical is prefered for the patients withsevere form of the disease. This case report describes a young woman with severe form of HS and its succesful treatment withcombination of antibiotics, adalimumab and surgical procedures.

Keywords: hidradenitis suppurativa, treatment, quality of life

Published: December 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fialová P, Vašků V. Successful treatment of hidradenitis suppurativa in young woman. Dermatol. praxi. 2018;12(4):191-194. doi: 10.36290/der.2018.031.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29: 619-644. Go to original source... Go to PubMed...
    2. Martorell A, García-Martínez FJ, Jiménez-Gallo D, et al. An update on hidradenitis suppurativa (Part I). Epidemiology, clinical Aspects, and definition of disease severity. Actas Dermosifiliogr 2015. http://dx.doi.org/10.1016/j.ad.2015.06.004 Go to original source...
    3. Dufour DN, Emstestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014; 1062(90): 216-221. Go to original source...
    4. Sabat, et al. Increased prevalence of metabolic syndrome in patiens with acne inversa. PLoS One 2012; 7: e31810. Go to original source... Go to PubMed...
    5. Gulliver W, Zouboulis CC, Prens E, et al. Evidence-based approach to treatment of hidradenitis suppurativa /acne inversa, based on the European guidelines for hidradenitis suppurativa, Rev Endocr Metab Disord DOI 10.1007/s11154-016-9328-5.
    6. Matusiak L, Bieniek A, Szepietowski JC. Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients. Br J Dermatol 2014; 171: 170-174. Go to original source...
    7. Ingram JR, Woo PN, Chua SL, et al. Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality. Br J Dermatol 2016; 174: 970-978. Go to original source...
    8. Slonková V. Možnosti léčby hidradenitis suppurativa. Dermatol. praxi 2017; 11(4): 170-172 Go to original source...
    9. Kim ES, Garnock-Jones KP, Keam SJ. Adalimumab: A Review in Hidradenitis Suppurativa. Am J Clin Dermatol 2016; 17: 545-552. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.